POR and osteosarcoma: A novel POR regulator, Zoledronic acid, was shown to increase ROS and lipid peroxidation levels in osteosarcoma cells through ferroptosis activation; it was also observed to be able to inhibit osteosarcoma growth in vivo using a BALB/c nude mice xenograft model (Jiacong et al., 2023).